ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $91 | -99.9% | 24,684 | -31.7% | 0.01% | -12.5% |
| Q3 2022 | $88,000 | +158.8% | 36,123 | +110.2% | 0.01% | +166.7% |
| Q2 2022 | $34,000 | -72.8% | 17,188 | -80.5% | 0.00% | -76.9% |
| Q4 2021 | $125,000 | -44.2% | 88,315 | -5.8% | 0.01% | -65.8% |
| Q3 2020 | $224,000 | +202.7% | 93,705 | +304.1% | 0.04% | +850.0% |
| Q4 2017 | $74,000 | – | 23,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |